Effects of a Lower Limb Strength Training Program on a Seated Robotic Device in Patients

NCT ID: NCT05020171

Last Updated: 2024-05-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

5 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-20

Study Completion Date

2024-01-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The loss of lower limb strength that occurs after an Acquired Brain Injury (ABI) limits the patient's autonomy in participating in activities of daily living, including gait performance. In the sub-acute phase, it is difficult to implement a strengthening program, as weakness prevents exercise being performed with the recommended parameters. This limit can be exceeded by using specific robotic devices, which allow the effort provided to be adapted according to the patient's capacities. In addition, motivation can be improved by the use of feedback or incentive games. The aim of this pilot study is to obtain data on the effect of lower limb strength training with a seated robotic device in subacute ABI patients for a future larger randomised study. In addition, it aims to evaluate the recruitment rate, applicability, resources for implementation and patient tolerance to the training program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

intervention group

group focus on lower limb strength training with a seated robotic device

Group Type EXPERIMENTAL

Group of strength training

Intervention Type DEVICE

2x a week during 5 weeks, strengthening of weak muscles with the intensity recommended in the literature, i.e. 3-4x15 repetition at an intensity of 50 to 80% of the maximum force combined with serious games to stimulate patient involvement in strength training

control group

physiotherapy group as usual, not focused on strength training

Group Type ACTIVE_COMPARATOR

Group of physiotherapy not focus on strength training

Intervention Type OTHER

2x a week during 5 weeks, active physical therapy treatment based on movement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Group of strength training

2x a week during 5 weeks, strengthening of weak muscles with the intensity recommended in the literature, i.e. 3-4x15 repetition at an intensity of 50 to 80% of the maximum force combined with serious games to stimulate patient involvement in strength training

Intervention Type DEVICE

Group of physiotherapy not focus on strength training

2x a week during 5 weeks, active physical therapy treatment based on movement

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acquired Brain Injury of vascular, traumatic, infectious or tumoral origin in the subacute phase
* Walking ability ≤ Functional Ambulatory Category level 5 (1-6)
* Paresis of the lower limb: strength \<57/100 on the Motricity Index
* Cognitive and memory functions allowing the patient to follow treatment instructions and give informed consent

Exclusion Criteria

* Significant heart problem
* Venous thrombosis less than 6 months
* Musculoskeletal impairment not compatible with movement
* Degenerative neurological disease
* Oxygen-dependent
* Blood pressure not stabilized
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institution de Lavigny

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Claude Pichonnaz, PhD

Role: PRINCIPAL_INVESTIGATOR

Haute Ecole de Santé Vaud

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institution de Lavigny

Lavigny, Canton of Vaud, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

14-O20

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

2021-00721

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.